EUVIMEDEUVIMED entdecken
Crossref

Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression

Brittany Schweiger, Forrest M Kievit

Experimental Brain Research · 2025

DOI: 10.1007/s00221-025-07018-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Brain Research, 2025. Verfasst von Brittany Schweiger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Systems Engineering, University of Nebraska, 4240 Fair St., 268 Morrison Center, Lincoln, NE, 68583, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Glioblastoma, Claudin-1, Brain Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Institute of Food and Agriculture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood-brain barrier (BBB) disruption is a well-known phenomenon in glioblastoma (GBM). However, the mechanism driving BBB dysfunction in previously established vasculature at the invasive edge of GBM is still unknown. In this study, we aimed to determine if GBM paracrine signaling is sufficient to induce BBB dysfunction and identify changes in the tight junctions of the BBB. An in vivo U-87 MG xenograft model and an in vitro primary brain endothelial cell BBB model were established for barrier dysfunction monitoring. Immunofluorescent staining revealed significantly higher claudin-1 expression and significantly lower claudin-5 expression in the tumor vs. normal brain tissue of our in vivo model (p < 0.01). Additionally, claudin-1 expression co-localized with brain cell type markers for endothelium, pericytes, and microglia. In vitro exposure of brain microvascular endothelial cells to GBM conditioned media resulted in a significant decrease in transendothelial electrical resistance as well as delocalization of claudin-5 from the tight junctions. These results suggest GBM cells secrete factors capable of inducing changes in the tight junction proteins of the BBB and decreasing barrier integrity. Future studies will aim to identify the mechanism in which these changes occur.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierGlioblastomaClaudin-1Brain NeoplasmsParacrine CommunicationHumansAnimalsMiceCell Line, TumorTight JunctionsEndothelial CellsClaudin-5Mice, Nude

Stichwörter der Autor:innen

Brain cancerClaudin-1Claudin-5Neurovascular unitPerivascular

Substanzen

Claudin-1Claudin-5CLDN1 protein, human

Autor:innen und Institutionen

  • Department of Biological Systems Engineering, University of Nebraska, 4240 Fair St., 268 Morrison Center, Lincoln, NE, 68583, USA.
  • Department of Biological Systems Engineering, University of Nebraska, 4240 Fair St., 268 Morrison Center, Lincoln, NE, 68583, USA. fkievit2@unl.edu.

Förderung

  • National Institute of Food and Agriculture

Zitieren

APA

Schweiger, B., & Kievit, F. M. (2025). Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression. Experimental Brain Research. https://doi.org/10.1007/s00221-025-07018-7

Vancouver

Schweiger B, Kievit FM. Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression. Experimental Brain Research. 2025. doi:10.1007/s00221-025-07018-7

BibTeX
@article{Schweiger2025,
  author = {Schweiger, Brittany and Kievit, Forrest M},
  title = {Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression},
  journal = {Experimental Brain Research},
  year = {2025},
  doi = {10.1007/s00221-025-07018-7}
}
Kostenlos starten →